blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1374895

EP1374895 - PHARMACEUTICAL COMPOSITION OF F(AB) 2 FRAGMENTS OF ANTIBODIES AND METHOD FOR THE PREPARATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.05.2011
Database last updated on 25.09.2024
Most recent event   Tooltip17.05.2013Lapse of the patent in a contracting state
New state(s): LU		published on 19.06.2013  [2013/25]
Applicant(s)For all designated states
Instituto Bioclon S.A. de CV.
Calzada de Tlalpan No. 4687 Col. Toriello Guerra Delegación Tlalpan
14050 México, D.F. / MX
[2009/45]
Former [2004/01]For all designated states
Lopez de Silanes, Juan
Lucerna No. 7, Col. Juarez
Delegacion Cuauhtémoc, Mexico D.F. 06600 / MX
For all designated states
Mancilla Nava, Rita
Calzada de Tlalpan No. 4687, Colonia Toriello Guerra
Delegacion Tlalpan, Mexico, D.F. 14050 / MX
For all designated states
Paniagua Solis, Jorge
Amores No. 1304, Colonia del Valle
Delegacion Benito Juarez, Mexico, D.F. 03100 / MX
Inventor(s)01 / Juan Lopez de Silanes
Lucerna No. 7, Col. Juarez
Delegacion Cuauthtémoc / MX
02 / Rita Mancilla Nava
Calzada de Tlalpan No. 4687, Colonia Toriello Guerra
Delegacion Tlalpan 14050 / MX
03 / Jorge F. Paniagua Solis
Amores No. 1304, Colonia del Valle
Delegacion Benito Juarez 03100 / MX
 [2010/13]
Former [2009/45]01 / Juan Lopez de Silanes
Lucerna No. 7, Col. Juarez
Delegacion Cuauthtémoc / MX
02 / Rita Mancilla Nava
Calzada de Tlalpan No. 4687, Colonia Toriello Guerra
Delegacion Tlalpan 14050 / MX
03 / Jorge Paniagua Solis
Amores No. 1304, Colonia del Valle
Delegacion Benito Juarez 03100 / MX
Former [2004/01]01 / see applicant
...
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstrasse 4
80802 München / DE
[N/P]
Former [2004/01]Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
Maximilianstrasse 58
80538 München / DE
Application number, filing date02703990.828.02.2002
[2004/01]
WO2002MX00013
Priority number, dateUS2001079807605.03.2001         Original published format: US 798076
[2004/41]
Former [2004/01]US2001079807628.02.2001
Filing languageES
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO02068475
Date:06.09.2002
Language:EN
[2002/36]
Type: A2 Application without search report 
No.:EP1374895
Date:02.01.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 06.09.2002 takes the place of the publication of the European patent application.
[2004/01]
Type: B1 Patent specification 
No.:EP1374895
Date:30.06.2010
Language:EN
[2010/26]
Search report(s)International search report - published on:EP31.10.2002
ClassificationIPC:A61K39/395, C07K16/18
[2004/01]
CPC:
C07K16/065 (EP,US); A61P37/06 (EP); A61P39/02 (EP);
C07K16/18 (EP,US); C07K16/241 (EP,US); C07K16/249 (EP,US);
A61K2039/505 (EP,US); C07K2317/54 (EP,US); Y10S424/809 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/01]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG AUS F(AB) 2- FRAGMENTEN VON ANTIKÖRPERN UND VERFAHREN ZU IHRER HERSTELLUNG[2004/01]
English:PHARMACEUTICAL COMPOSITION OF F(AB) 2 FRAGMENTS OF ANTIBODIES AND METHOD FOR THE PREPARATION THEREOF[2004/01]
French:COMPOSITION PHARMACEUTIQUE DE FRAGMENTS F(AB) 2 D'ANTICORPS ET PROCEDE DE PREPARATION[2004/01]
Entry into regional phase29.09.2003Translation filed 
29.09.2003National basic fee paid 
29.09.2003Designation fee(s) paid 
29.09.2003Examination fee paid 
Examination procedure07.10.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.09.2003Examination requested  [2004/01]
20.05.2005Amendment by applicant (claims and/or description)
15.06.2007Despatch of a communication from the examining division (Time limit: M06)
21.12.2007Reply to a communication from the examining division
05.03.2009Cancellation of oral proceeding that was planned for 28.04.2009
05.03.2009Minutes of oral proceedings despatched
08.04.2009Despatch of a communication from the examining division (Time limit: M02)
27.04.2009Date of oral proceedings
28.04.2009Date of oral proceedings
28.04.2009Date of oral proceedings (cancelled)
29.05.2009Reply to a communication from the examining division
23.07.2009Communication of intention to grant the patent
18.11.2009Fee for grant paid
18.11.2009Fee for publishing/printing paid
Opposition(s)31.03.2011No opposition filed within time limit [2011/23]
Fees paidRenewal fee
20.02.2004Renewal fee patent year 03
25.02.2005Renewal fee patent year 04
23.02.2006Renewal fee patent year 05
27.02.2007Renewal fee patent year 06
28.02.2008Renewal fee patent year 07
04.05.2009Renewal fee patent year 08
29.12.2009Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
28.02.200908   M06   Fee paid on   04.05.2009
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY30.06.2010
FI30.06.2010
PT02.11.2010
CH28.02.2011
IE28.02.2011
LI28.02.2011
LU28.02.2011
MC28.02.2011
[2013/25]
Former [2012/08]CY30.06.2010
FI30.06.2010
PT02.11.2010
CH28.02.2011
IE28.02.2011
LI28.02.2011
MC28.02.2011
Former [2011/48]CY30.06.2010
FI30.06.2010
PT02.11.2010
CH28.02.2011
LI28.02.2011
MC28.02.2011
Former [2011/45]CY30.06.2010
FI30.06.2010
PT02.11.2010
MC28.02.2011
Former [2011/13]CY30.06.2010
FI30.06.2010
PT02.11.2010
Former [2011/10]FI30.06.2010
PT02.11.2010
Former [2010/50]FI30.06.2010
Cited inInternational search[Y]US4806346  (HUM WAH-TUNG [US], et al) [Y] 1,5-8,10-13,17,19-26 * the whole document *;
 [A]US4849352  (SULLIVAN JOHN B [US], et al) [A] * the whole document *;
 [A]US5328834  (NGO THAT T [US], et al) [A] * the whole document *;
 [A]ES2106183T  (THERAPEUTIC ANTIBODIES INC) [A] * the whole document *;
 [Y]US5733742  (LANDON JOHN [GB]) [Y] 1,5-8,10-13,17,19-26 * column 5, line 46 - line 55; claims 1-9 *
by applicantUS4806346
 US4940670
 US5888511
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.